Home Biosimilar Antibodies Protein Tyrosine Kinase VEGFR antibody Parsatuzumab (Anti-EGFL7) For research use only.
Not for use in humans.

Parsatuzumab (Anti-EGFL7)

Synonyms: Anti-EGFL7; RG 7414

Parsatuzumab (Anti-EGFL7) is a humanized monoclonal antibody targeting EGFL7. Parsatuzumab selectively blocks the interaction between EGFL7 and endothelial cells, potentially inhibiting vascular regrowth and reducing vascular endothelial growth factor (VEGF) inhibition. MW: 145.5 KD.

Parsatuzumab (Anti-EGFL7)

Purity & Quality Control

≥99

Choose Selective VEGFR Inhibitors

Biological Activity

Description Parsatuzumab (Anti-EGFL7) is a humanized monoclonal antibody targeting EGFL7. Parsatuzumab selectively blocks the interaction between EGFL7 and endothelial cells, potentially inhibiting vascular regrowth and reducing vascular endothelial growth factor (VEGF) inhibition. MW: 145.5 KD.

Product Details

CAS No. 1312797-14-0
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Parsatuzumab (Anti-EGFL7) | Parsatuzumab (Anti-EGFL7) supplier | purchase Parsatuzumab (Anti-EGFL7) | Parsatuzumab (Anti-EGFL7) cost | Parsatuzumab (Anti-EGFL7) manufacturer | order Parsatuzumab (Anti-EGFL7) | Parsatuzumab (Anti-EGFL7) distributor